These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25963982)

  • 1. In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
    Hindler JA; Wong-Beringer A; Charlton CL; Miller SA; Kelesidis T; Carvalho M; Sakoulas G; Nonejuie P; Pogliano J; Nizet V; Humphries R
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4279-88. PubMed ID: 25963982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
    Sakoulas G; Bayer AS; Pogliano J; Tsuji BT; Yang SJ; Mishra NN; Nizet V; Yeaman MR; Moise PA
    Antimicrob Agents Chemother; 2012 Feb; 56(2):838-44. PubMed ID: 22123698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an
    Jahanbakhsh S; Singh NB; Yim J; Kebriaei R; Smith JR; Lev K; Tran TT; Rose WE; Arias CA; Rybak MJ
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094136
    [No Abstract]   [Full Text] [Related]  

  • 4. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
    Smith JR; Barber KE; Raut A; Aboutaleb M; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2015; 70(6):1738-43. PubMed ID: 25645208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR; Yim J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
    Kebriaei R; Stamper KC; Singh KV; Khan A; Rice SA; Dinh AQ; Tran TT; Murray BE; Arias CA; Rybak MJ
    J Infect Dis; 2020 Oct; 222(9):1531-1539. PubMed ID: 32514561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
    Rand KH; Houck H
    J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium.
    Sakoulas G; Rose W; Nonejuie P; Olson J; Pogliano J; Humphries R; Nizet V
    Antimicrob Agents Chemother; 2014; 58(3):1494-500. PubMed ID: 24366742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.
    Kebriaei R; Rice SA; Singh KV; Stamper KC; Dinh AQ; Rios R; Diaz L; Murray BE; Munita JM; Tran TT; Arias CA; Rybak MJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760141
    [No Abstract]   [Full Text] [Related]  

  • 11. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation
    Kunz Coyne AJ; Stamper K; El Ghali A; Kebriaei R; Biswas B; Wilson M; Deschenes MV; Tran TT; Arias CA; Rybak MJ
    Microbiol Spectr; 2023 Aug; 11(4):e0034023. PubMed ID: 37338375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs.
    Diaz L; Tran TT; Munita JM; Miller WR; Rincon S; Carvajal LP; Wollam A; Reyes J; Panesso D; Rojas NL; Shamoo Y; Murray BE; Weinstock GM; Arias CA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4527-34. PubMed ID: 24867964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.
    Luther MK; Arvanitis M; Mylonakis E; LaPlante KL
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4612-20. PubMed ID: 24867993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.
    Snydman DR; McDermott LA; Jacobus NV
    J Chemother; 2005 Dec; 17(6):614-21. PubMed ID: 16433191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.
    Munita JM; Panesso D; Diaz L; Tran TT; Reyes J; Wanger A; Murray BE; Arias CA
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4354-9. PubMed ID: 22664970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
    J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE.
    Werth BJ; Barber KE; Tran N; Nonejuie P; Sakoulas G; Pogliano J; Rybak MJ
    J Antimicrob Chemother; 2015 Feb; 70(2):489-93. PubMed ID: 25304643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.